March 2012 FDA Recall Drug by Shionogi Inc.
D-1398-2012 - Failed USP Dissolution Test Requirements
This Class II drug recall was voluntarily initiated by Shionogi Inc. on March 8, 2012 for the product Drug. The FDA reported the reason for recall as failed usp dissolution test requirements. The product was distributed in PA and the recall is currently terminated.
Recall Number: D-1398-2012
Failed USP Dissolution Test Requirements: Out of Specification dissolution result at 18 month time point
03-08-2012
07-04-2012
7230 bottles
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Shionogi Inc.
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
PA
02-07-2013
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Nisoldipine Extended Release Tablets, 17mg, 100 count bottle, Rx only, Manufactured for: Prasco Laboratories Mason OH 45040, Manufactured by SkyePharma production SAS 38297, Saint Quentin-Pallavier, France, NDC: 0677-1979-01
Batch or Lot Expiration Information
Lot# Lot number: 2021956, Exp; 01/2013